Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03457116 · ClinicalTrials.gov registry record · Phase 4

Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty

A Phase 4 study of Opioid Use and Rhinoplasty, sponsored by NYU Langone Health.

Completed
Registry status
Phase 4
Development phase
70
Enrollment target
1
Study location

NCT03457116 is a Phase 4 study of Opioid Use and Rhinoplasty that has completed, run by NYU Langone Health. The registered enrollment target is 70 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03457116, a Phase 4 study of Opioid Use and Rhinoplasty, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
Phase 4
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain control methods. Patients will be randomized to receive either NSAIDs in the form of 400mg of Ibuprofen or Norco (hydrocodone 5mg- acetaminophen 325mg) to be used for post-operative pain. The study will then compare which is more effective in controlling post operative pain.

Interventions

  • DRUG NSAID
  • DRUG Norco

Study Locations (1)

New York

  • NYU Langone Medical Center - New York

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2018-01-30
Est. Completion 2020-11-02
Phase Phase 4

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03457116

The ClinicalTrials.gov registry entry for NCT03457116 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which NSAID is the first listed.

NCT03457116 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03457116 about?

NCT03457116 is a clinical study titled "Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty". The purpose of this study is to compare the efficacy and safety of oral opiate pain medication vs non-steroidal ant inflammatory drugs (NSAIDs) in the treatment of postoperative rhinoplasty pain. This study will also evaluate potential contributing factors affecting the efficacy of these pain contro...

What is the current status of trial NCT03457116?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2018-01-30. Estimated completion is 2020-11-02.

What conditions does trial NCT03457116 study?

This clinical trial studies the following conditions: Opioid Use, Rhinoplasty, Non-steroidal Ant Inflammatory Drugs.

What interventions are being tested in trial NCT03457116?

The interventions under investigation include: NSAID (DRUG), Norco (DRUG).

Who is sponsoring clinical trial NCT03457116?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03457116 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.